Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
Nedisertib
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1448181-48-4
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Vertex_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
VX-478
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
ATR kinase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
ATR protein
|
| gptkbp:bfsParent |
gptkb:Amprenavir
|
| gptkbp:bfsLayer |
7
|